Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2019-12-30 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
关于公司设立以来股本演变情况的说明及其董事、监事、高级管理人员的确认意见
Major Shareholding Notification Classification · 95% confidence The document is a detailed explanation and confirmation regarding the evolution of the company's share capital since its establishment. It includes comprehensive historical data on capital increases, share transfers, shareholder structure changes, and related official approvals and audit confirmations. The document is addressed to the China Securities Regulatory Commission and contains no financial statements or earnings data but focuses on the company's capital structure history and shareholder information. This type of document is best classified as a Major Shareholding Notification (MRQ) because it details changes in significant share ownership levels and capital structure over time, including share transfers and capital increases. It is not an announcement of a report, nor a full financial report, nor a regulatory filing of a different nature. The length and detail support a confident classification as MRQ.
2019-12-30 Chinese
上海市锦天城律师事务所关于公司首次公开发行股票并在创业板上市的补充法律意见书（四）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding Zhejiang Tailin Biotechnology Co., Ltd.'s initial public offering (IPO) and listing on the ChiNext board. It includes legal opinions, verification of compliance with securities laws, shareholder and management information, and references to audit reports and other legal documents related to the IPO process. The document is not a financial report, earnings release, or a simple announcement but a comprehensive legal opinion supporting the IPO. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory compliance document related to the IPO process and does not fit into other specific categories like Annual Report or Capital/Financing Update. The document length (15,000 characters) and content confirm it is not a brief announcement or a certification letter but a substantive legal filing.
2019-12-30 Chinese
上海市锦天城律师事务所关于公司首次公开发行股票并在创业板上市的补充法律意见书（十四）
Legal Proceedings Report Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding Zhejiang Tailin Biotechnology Co., Ltd.'s initial public offering (IPO) and listing on the Growth Enterprise Market (创业板). It includes extensive legal opinions, definitions, and verification of compliance with relevant laws and regulations, as well as detailed information about shareholders, business operations, and related legal matters. The document references multiple prior legal opinion letters and audit reports, and it is clearly related to the IPO process and legal compliance for the issuance of new shares and listing. This type of document is a legal proceeding report related to the IPO process, not a financial report, earnings release, or management report. It is not a simple announcement but a substantive legal opinion document. Therefore, the most appropriate classification is Legal Proceedings Report (LTR).
2019-12-30 Chinese
关于公司最近三年及一期非经常性损益的鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "鉴证报告" which translates to an "Assurance Report" or "Verification Report" related to non-recurring gains and losses for the recent three years and one period. It includes detailed financial tables and notes about these non-recurring items. The report is prepared by an accounting firm and is intended for use in the company's initial public offering (IPO) filing. The content is focused on auditing and verifying specific financial details rather than presenting a full annual or interim report. It is a standalone audit-related report providing an independent opinion on a specific financial aspect, not a full annual report or earnings release. Therefore, it fits the category of an Audit Report / Information (AR). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement or certification letter. Hence, the classification is AR with high confidence.
2019-12-30 Chinese
审计报告
Regulatory Filings
2019-12-30 Chinese
首次公开发行股票并在创业板上市网上路演公告
Investor Presentation Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) of Zhejiang Tailin Biotechnology Co., Ltd., including details about the stock issuance, pricing, subscription process, and an online roadshow event. It mentions the approval by the China Securities Regulatory Commission and provides instructions for investors. The document does not contain financial statements or detailed financial analysis but serves as an informational notice about the IPO and related investor presentation event. It is not a full report, earnings release, or regulatory filing of financial data. Given the focus on the online roadshow and investor information, this fits best as an Investor Presentation (IP) category rather than a formal report or regulatory filing.
2019-12-30 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.